Array comparative genomic hybridization analysis of uterine leiomyosarcoma

Area of Science:

• Genomics and Molecular Biology
• Oncology
• Gynecologic Pathology

Background:

• Uterine leiomyosarcoma is a rare malignancy with poorly understood genetic underpinnings.
• Distinguishing malignant uterine leiomyosarcoma from benign uterine leiomyoma is crucial for appropriate clinical management.

Purpose of the Study:

• To identify DNA copy number alterations in uterine leiomyosarcoma using genome-wide array-based comparative genomic hybridization (array-CGH).
• To compare the genomic profiles of uterine leiomyosarcoma with benign uterine leiomyoma.

Main Methods:

• Analyzed DNA from 7 uterine leiomyosarcoma and 4 uterine leiomyoma cases using array-CGH.
• Microdissection of paraffin-fixed tissues and DNA extraction were performed.
• Fluorescence in situ hybridization (FISH) and analysis against the Gene Ontology database were utilized.

Main Results:

• Uterine leiomyoma samples showed no genetic alterations.
• All 7 uterine leiomyosarcoma cases exhibited specific DNA copy number gains and losses.
• Recurrent regions of loss were identified, particularly on chromosomes 1p, 9p, and 14q, with specific genes like TIM1, PDGFR-beta, and ERCC5 frequently affected.

Conclusions:

• Array-CGH effectively identified chromosomal aberrations associated with uterine leiomyosarcoma.
• The high resolution of array-CGH aids in pinpointing potential driver genes within gained or lost genomic regions.
• Genomic profiling provides insights into the molecular pathogenesis of uterine leiomyosarcoma.